Diagnostics

Medical Device Market Surges to USD 750 Billion by 2033, Propelled by 5.5% CAGR – Verified Market Reports®

The Medical Device Market is witnessing robust expansion driven by rising healthcare expenditure, growing prevalence of chronic diseases, and accelerating...

MedCognetics Collaborates With Laurel Bridge Software to Revolutionize Breast Cancer Screening and Diagnosis With Secure, Advanced AI Workflow Solutions

NEWARK, DELAWARE / ACCESS Newswire / October 23, 2025 / MedCognetics, a pioneer in artificial intelligence (AI) for breast cancer...

Hemostemix Granted Trademark “KNOW YOUR HEALTH” in Japan, International Registration No. 1744775 Covers Stem Cell Preparations and Research in Classes 1, 5, 42

Calgary, Alberta--(Newsfile Corp. - October 22, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...

HLTH 2025: 150 Past Attendees and Investors Identify Their Five AI Platform Categories Set to Displace Legacy Health IT in 2026

Compiled by Black Book Research from VC PE and banking investors, the briefing ranks which AI-driven categories are converting pilots...

Peer-Reviewed Journal of Clinical Psychiatry Publishes Mentavi’s Online ADHD Diagnostic Evaluation Validation Study

Open-access publication demonstrates the validity and reliability of the Mentavi online Diagnostic Evaluation compared to a clinical interview, widening evidence...

ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025

error: Content is protected !!